Wietske Kievit

6.3k citations
175 papers · 4.3k · h-index 38

Impact in

  • Rheumatology top 0.5%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
  • Immunology top 2%
    • Psoriasis: Treatment and Pathogenesis

Papers in

  • Rheumatology 48
    • Rheumatoid Arthritis Research and Therapies 45
    • Systemic Lupus Erythematosus Research 6
  • Immunology 29
    • Psoriasis: Treatment and Pathogenesis 23
Co-authors
Piet L. C. M. van Riel (29 shared papers)Jaap Fransen (24 shared papers)Alfons A den Broeder (17 shared papers)E.M.G.J. de Jong (31 shared papers)Joost P.H. Drenth (34 shared papers)P.C.M. van de Kerkhof (20 shared papers)Tim Jansen (16 shared papers)Eddy Adang (11 shared papers)
Journals
British Journal of Dermatology (12 papers)Annals of the Rheumatic Diseases (10 papers)Lara D. Veeken (7 papers)Arthritis Care & Research (7 papers)Acta Dermato Venereologica (6 papers)
Partner nations
NetherlandsUnited StatesBelgium

In The Last Decade

Wietske Kievit

172 papers receiving 4.2k citations

Peers

Wietske Kievit
Comparison fields: 5 of 119
  • Rheumatology 1.5k
  • Immunology 900
  • Dermatology 274
  • Hematology 315
  • Pathology and Forensic Medicine 352
Replace Alejandro Balsa with:
Alejandro Balsa Spain
Huifeng Yun United States
Carl A. Laskin Canada
Carl Turesson Sweden
Peter Izmirly United States
Megan E. B. Clowse United States
Dolors Tàssies Spain
Sandra Navarra Philippines
Joan Carles Reverter Spain
Maria Greenwald United States
Wietske Kievit relative to Alejandro Balsa Spain Alejandro Balsa's profile →
Citations per field
00.5×2×3.3×
Alejandro Balsa · 1×
Citations per year

Countries citing papers authored by Wietske Kievit

Since Specialization
Citations

This map shows the geographic impact of Wietske Kievit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wietske Kievit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wietske Kievit more than expected).

Fields of papers citing papers by Wietske Kievit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wietske Kievit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wietske Kievit. The network helps show where Wietske Kievit may publish in the future.

Co-authors

The 25 scholars most cited alongside Wietske Kievit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wietske Kievit Line = papers co-authored together Wietske Kievit links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 175 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent‐onset rheumatoid arthritis
Arthritis & Rheumatism ·Judith A.M. Wessels, S M van der Kooij, Saskia le Cessie, Wietske Kievit, Pilar Barerra, Cornelia F Allaart, T. Huizinga, Henk‐Jan Guchelaar
2007191
2
The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice
Annals of the Rheumatic Diseases ·Wietske Kievit, Jaap Fransen, Anke Oerlemans, H. H. Kuper, M A F J van der Laar, D. J. R. A. M. DE ROOIJ, C.M.A. de Gendt, Karel Ronday, Tim Jansen, P.C.M. van Oijen, H.L.M. Brus, Eddy Adang, Piet L. C. M. van Riel
2007153
3
Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial
BMJ ·Noortje van Herwaarden, Aatke van der Maas, M.J.M. Minten, F.H.J. van den Hoogen, Wietske Kievit, Ronald van Vollenhoven, J. W. J. Bijlsma, Bart J. F. van den Bemt, Alfons A den Broeder
2015135
4
Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
Annals of the Rheumatic Diseases ·S. A. A. van Dartel, Jaap Fransen, Wietske Kievit, Marcel Flendrie, Alfons A den Broeder, Henk Visser, A Hartkamp, Mart A F J van de Laar, Piet L. C. M. van Riel
2012125
5
Long-term effectiveness and safety of TNF-blocking agents in daily clinical practice: results from the Dutch Rheumatoid Arthritis Monitoring register
Lara D. Veeken ·Wietske Kievit, Jaap Fransen, Eddy Adang, Alfons A den Broeder, Hein J. Bernelot Moens, Henk Visser, M. A. F. van de Laar, P. L. C. M. van Riel
201095
6
Prior Colorectal Neoplasia Is Associated With Increased Risk of Ileoanal Pouch Neoplasia in Patients With Inflammatory Bowel Disease
Gastroenterology ·Lauranne Derikx, Wietske Kievit, Joost P.H. Drenth, Dirk J. de Jong, Cyriel Y. Ponsioen, Bas Oldenburg, Andrea E. van der Meulen‐de Jong, Gerard Dijkstra, M.J.A.L. Grubben, Cornelis J. H. M. van Laarhoven, Irıs D. Nagtegaal, Frank Hoentjen
201393
7
Drug Survival Studies in Dermatology:Principles, Purposes, and Pitfalls
Journal of Investigative Dermatology ·J.M.P.A. van den Reek, Wietske Kievit, Robert Gniadecki, Jelle J. Goeman, Jeffrey Zweegers, P.C.M. van de Kerkhof, Marieke M.B. Seyger, E.M.G.J. de Jong
201592
8
The effectiveness and medication costs of three anti-tumour necrosis factor α agents in the treatment of rheumatoid arthritis from prospective clinical practice data
Annals of the Rheumatic Diseases ·Wietske Kievit, Eddy Adang, Jaap Fransen, H. H. Kuper, M.A.F.J. van de Laar, Tim Jansen, C.M.A. de Gendt, D-J R A M de Rooij, H.L.M. Brus, P.C.M. van Oijen, Piet C.L.M. van Riel
200891
9
Down-titration and discontinuation of infliximab in rheumatoid arthritis patients with stable low disease activity and stable treatment: an observational cohort study
Annals of the Rheumatic Diseases ·Aatke van der Maas, Wietske Kievit, Bart J. F. van den Bemt, F.H.J. van den Hoogen, Piet L. van Riel, Alfons A den Broeder
201286
10
Influence of age on the outcome of antitumour necrosis factor alpha therapy in rheumatoid arthritis
Annals of the Rheumatic Diseases ·B J Radovits, Wietske Kievit, Jaap Fransen, M.A.F.J. van de Laar, Tim Jansen, Piet L. C. M. van Riel, Roland Laan
200880
11
‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTUREnetwork
British Journal of Dermatology ·J. M. P. A. van den Reek, Jeffrey Zweegers, Wietske Kievit, Marisol E. Otero, P.P.M. van Lümig, R.J.B. Driessen, Paul M. Ossenkoppele, M.D. Njoo, J.M. Mommers, M.I.A. Koetsier, W.P. Arnold, B.A.M. Sybrandy‐Fleuren, A.L.A. Kuijpers, M.P.M. Andriessen, P.C.M. van de Kerkhof, Marieke M.B. Seyger, E.M.G.J. de Jong
201478
12
Cost effectiveness of a new strategy to identify HNPCC patients
Gut ·Wietske Kievit, J H F M de Bruin, E. M. Adang, Johan L. Severens, J H Kleibeuker, Rolf H. Sijmons, Theo J. M. Ruers, F. M. Nagengast, Hans F. A. Vasen, J. Han van Krieken, Marjolijn J. L. Ligtenberg, (unknown)
200471
13
Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-t
British Journal of Dermatology ·Jeffrey Zweegers, J.M.P.A. van den Reek, P.C.M. van de Kerkhof, Marisol E. Otero, A.L.A. Kuijpers, M.I.A. Koetsier, W.P. Arnold, M.A.M. Berends, Lizelotte J.M.T. Weppner‐Parren, Paul M. Ossenkoppele, M.D. Njoo, J.M. Mommers, P.P.M. van Lümig, R.J.B. Driessen, Wietske Kievit, E.M.G.J. de Jong
201662
14
Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: Results of a maximum difference scaling experiment
Arthritis Care & Research ·L. T. C. van Hulst, Wietske Kievit, R. van Bommel, Piet L. C. M. van Riel, Liana Fraenkel
201158
15
Taurolidine Lock Is Superior to Heparin Lock in the Prevention of Catheter Related Bloodstream Infections and Occlusions
PLoS ONE ·E.D. Olthof, Michelle W. J. Versleijen, Getty Huisman‐de Waal, Ton Feuth, Wietske Kievit, Geert Wanten
201458
16
Current clinical selection strategies for identification of hereditary non‐polyposis colorectal cancer families are inadequate: a meta‐analysis
Clinical Genetics ·Wietske Kievit, JHFM De Bruin, EMM Adang, (unknown), F. M. Nagengast, Jhjm Van Krieken, (unknown)
200457
17
Gout Is a Chronic Inflammatory Disease in Which High Levels of Interleukin‐8 (CXCL8), Myeloid‐Related Protein 8/Myeloid‐Related Protein 14 Complex, and an Altered Proteome Are Associated With Diabetes Mellitus and Cardiovascular Disease
Arthritis & Rheumatology ·Laura B.E. Kienhorst, Ellen van Lochem, Wietske Kievit, Nicola Dalbeth, Marilyn E. Merriman, Amanda Phipps‐Green, Arnoud Loof, Waander L. van Heerde, Sita H. Vermeulen, Lisa K. Stamp, Elly van Koolwijk, Jacqueline de Graaf, Dirk Holzinger, Johannes Roth, M. Janssen, Tony R. Merriman, Jasper Broen, Timothy R. D. J. Radstake
201554
18
Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial
Arthritis Research & Therapy ·S. Manders, Wietske Kievit, Eddy Adang, Herman L. M. Brus, Hein J. Bernelot Moens, A Hartkamp, Lidy Hendriks, Elisabeth Brouwer, Henk Visser, Harald E. Vonkeman, Jos Hendrikx, Tim Jansen, René Westhovens, Mart AFJ van de Laar, Piet LCM van Riel
201554
19
Epstein–Barr Virus in Inflammatory Bowel Disease: The Spectrum of Intestinal Lymphoproliferative Disorders
Journal of Crohn s and Colitis ·Loes H.C. Nissen, Irıs D. Nagtegaal, Dirk J. de Jong, Wietske Kievit, Lauranne Derikx, Patricia J.T.A. Groenen, J. Han van Krieken, Frank Hoentjen
201553
20
An increased risk of non‐melanoma skin cancer during TNF‐inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease‐related factors
Journal of the European Academy of Dermatology and Venereology ·P.P.M. van Lümig, S.P. Menting, J. M. P. A. van den Reek, Phyllis I. Spuls, Piet L. C. M. van Riel, P.C.M. van de Kerkhof, Jaap Fransen, Wietske Kievit, E.M.G.J. de Jong
201453

About Wietske Kievit

Wietske Kievit is a scholar working on Rheumatology, Immunology, Genetics, Surgery and Oncology, having authored 175 papers that have together received 4.3k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (45 papers), Psoriasis: Treatment and Pathogenesis (23 papers), Genetic and Kidney Cyst Diseases (9 papers), Inflammatory Bowel Disease (8 papers), Hepatitis C virus research (6 papers), Systemic Lupus Erythematosus Research (6 papers), Dermatology and Skin Diseases (6 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). The work is most often cited by research in Rheumatology (1.5k citations), Immunology (900 citations), Dermatology (274 citations), Hematology (315 citations) and Pathology and Forensic Medicine (352 citations). Wietske Kievit has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Piet L. C. M. van Riel, Jaap Fransen, Alfons A den Broeder, E.M.G.J. de Jong, Joost P.H. Drenth, P.C.M. van de Kerkhof, Tim Jansen, Eddy Adang, Henk Visser and Marieke M.B. Seyger. Their work appears in journals such as British Journal of Dermatology, Annals of the Rheumatic Diseases, Lara D. Veeken, Arthritis Care & Research and Acta Dermato Venereologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alejandro BalsaBreakdown of academic impact, for papers by Huifeng YunBreakdown of academic impact, for papers by Carl A. LaskinBreakdown of academic impact, for papers by Carl TuressonBreakdown of academic impact, for papers by Peter IzmirlyBreakdown of academic impact, for papers by Megan E. B. ClowseBreakdown of academic impact, for papers by Dolors TàssiesBreakdown of academic impact, for papers by Sandra NavarraBreakdown of academic impact, for papers by Joan Carles ReverterBreakdown of academic impact, for papers by Maria Greenwald